DrugDashboards

Artificial Tears

Artificial Tears · DEXTRAN 70 1 mg/mL; GLYCERIN 2 mg/mL; HYPROMELLOSES 3 mg/mL · Solution/ Drops · Ophthalmic · AvPAK

NDC 50268-0043-15 · 15 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.4038 per mL over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Feb 2025Jan 2026$0.4038
12 price points · per ML · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$6.44
Reported to Texas DSHS · 2026 annual filing · AvKare

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$38,180
3,399 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.0%chance of a new FDA shortage posting for artificial tears (other) in the next 90 days

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M018
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingApr 23, 2025
    BRS Analytical Services, LLCcGMP deviations and lack of assurance of sterility.

Manufacturers of Artificial Tears (Solution/ Drops)

LabelerStrengthFirst seenLast seen
AvPAKDEXTRAN 70 1 mg/mL; GLYCERIN 2 mg/mL; HYPROMELLOSES 3 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Artificial Tears — NDC 50268-0043-15," retrieved September 3, 2026, https://drugdashboards.com/drug/50268004315.

Free to cite with attribution — see how the data is put together.